We are live on ! Find out more
AP

Appleton Partners Portfolio holdings

AUM $1.63B
1-Year Est. Return 38.57%
This Fund
S&P 500
This Quarter Est. Return
+0.6%
1 Year Est. Return
+38.57%
3 Year Est. Return
+101.09%
5 Year Est. Return
+116.43%
10 Year Est. Return
+424.6%
AUM
$489M
AUM Growth
-$16.7M
Cap. Flow
-$15M
Cap. Flow %
-3.06%
Top 10 Hldgs %
23.12%
Holding
214
New
8
Increased
52
Reduced
123
Closed
10

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$3.94M
2
AGN
Allergan plc
AGN
+$3.03M
3
AMZN icon
Amazon
AMZN
+$2.76M
4
AVGO icon
Broadcom
AVGO
+$1.42M
5
DLTR icon
Dollar Tree
DLTR
+$1.18M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$4.25M
2
C icon
Citigroup
C
+$3.43M
3
UAA icon
Under Armour
UAA
+$1.92M
4
GILD icon
Gilead Sciences
GILD
+$1.44M
5
ROP icon
Roper Technologies
ROP
+$1.33M

Sector Composition

Rank Sector Weight
1 Healthcare 17.15%
2 Financials 15.07%
3 Technology 13.59%
4 Consumer Discretionary 11.59%
5 Consumer Staples 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APTV icon
76
Aptiv
APTV
$12B
$1.56M 0.32%
24,939
-60,871
-71% -$4.25M
CAH icon
77
Cardinal Health
CAH
$53.3B
$1.55M 0.32%
19,878
-3,500
-15% -$279K
INTC icon
78
Intel
INTC
$481B
$1.54M 0.32%
46,980
-3,349
-7% -$105K
UNP icon
79
Union Pacific
UNP
$183B
$1.52M 0.31%
17,470
-2,168
-11% -$183K
EA icon
80
Electronic Arts
EA
$52.4B
$1.5M 0.31%
19,815
+2,960
+18% +$208K
PNC icon
81
PNC Financial Services
PNC
$100B
$1.5M 0.31%
18,408
-715
-4% -$61.5K
ILMN icon
82
Illumina
ILMN
$29.5B
$1.45M 0.3%
10,614
-9,272
-47% -$1.32M
KO icon
83
Coca-Cola
KO
$353B
$1.41M 0.29%
31,131
-647
-2% -$29.2K
ABT icon
84
Abbott
ABT
$180B
$1.39M 0.28%
35,388
-269
-0.8% -$10.7K
APH icon
85
Amphenol
APH
$190B
$1.35M 0.28%
94,376
-3,596
-4% -$51.7K
HON icon
86
Honeywell
HON
$76.4B
$1.28M 0.26%
12,292
+351
+3% +$36.1K
CHD icon
87
Church & Dwight Co
CHD
$23B
$1.27M 0.26%
24,652
-200
-0.8% -$9.65K
TGT icon
88
Target
TGT
$62.4B
$1.23M 0.25%
17,550
RTN
89
DELISTED
Raytheon Company
RTN
$1.19M 0.24%
8,726
+101
+1% +$13.2K
T icon
90
AT&T
T
$163B
$1.18M 0.24%
36,033
+1,490
+4% +$44.3K
AMAT icon
91
Applied Materials
AMAT
$435B
$1.15M 0.24%
48,010
+660
+1% +$14.6K
RTX icon
92
RTX Corp
RTX
$287B
$1.15M 0.24%
17,838
-370
-2% -$23.7K
SMG icon
93
ScottsMiracle-Gro
SMG
$4.04B
$1.12M 0.23%
16,008
-540
-3% -$37.5K
TXN icon
94
Texas Instruments
TXN
$256B
$1.09M 0.22%
17,448
+424
+2% +$25.2K
VFC icon
95
VF Corp
VFC
$6.72B
$1.09M 0.22%
18,836
-2,547
-12% -$151K
DLR icon
96
Digital Realty Trust
DLR
$75.2B
$1.08M 0.22%
9,941
+603
+6% +$57.2K
NVS icon
97
Novartis
NVS
$296B
$1.04M 0.21%
14,059
-2,372
-14% -$164K
ADP icon
98
Automatic Data Processing
ADP
$99B
$1.03M 0.21%
11,267
NKE icon
99
Nike
NKE
$62.1B
$1.01M 0.21%
18,292
-2,800
-13% -$160K
SYK icon
100
Stryker
SYK
$126B
$992K 0.2%
8,281
+3,836
+86% +$429K

Similar funds

Appleton Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Appleton Partners held 214 positions worth $489M, down 3.3% from $506M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Appleton Partners withdrew a net $15M in Q2 2016, closing 10 positions and reducing 123 holdings. Its most notable exit was Perrigo, an estimated $412K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Appleton Partners opened a new position in UnitedHealth worth $4.17M.

  • Appleton Partners's largest Q2 2016 buy was UnitedHealth: 29,523 shares worth $4.17M.
  • Appleton Partners added most to Allergan plc in Q2 2016, an estimated $3.03M increase.
  • Appleton Partners's biggest Q2 2016 reduction was Aptiv, cutting an estimated $4.25M.
  • Appleton Partners fully exited Perrigo in Q2 2016, selling an estimated $412K.
  • Appleton Partners's ten largest holdings make up 23% of its $489M portfolio in Q2 2016.
  • Appleton Partners opened 8 new positions and closed 10 in Q2 2016.
  • Appleton Partners's portfolio value fell 3.3% quarter-over-quarter to $489M.

Based on Appleton Partners's 13F filing for Q2 2016, filed 3 Aug 2016.